UAE opens regional COVID-19 vaccination site for Chinese nationals | Inquirer News

UAE opens regional COVID-19 vaccination site for Chinese nationals

/ 01:41 PM May 25, 2021

DUBAI — The United Arab Emirates will offer China’s Sinopharm vaccine to Chinese nationals visiting the regional tourism and business hub, the first non-residents to be eligible for the country’s vaccination campaign against COVID-19.

Chinese nationals over the age of 16 holding a short-term visa can receive two doses of Sinopharm in Dubai, the state news agency WAM said earlier this week, under an agreement between the UAE and China to launch a regional vaccination site.

The UAE led Phase III clinical trials of the vaccine produced by China’s state-owned drugmaker Sinopharm and has started manufacturing it under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42.

Article continues after this advertisement

The Gulf Arab state, a country of some 9 million people, has vaccinated about 73% of its eligible population, authorities have said.

FEATURED STORIES

It recorded 1,512 new COVID-19 infections on Monday to take its total to 557,610 cases and 1,654 deaths.

The UAE, which is offering four vaccines, said this month it would start offering a booster shot of Sinopharm.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: China, COVID-19, Sinopharm, UAE

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.